Re: PC Adams. Genetic testing for hemochromatosis: Diagnostic or confirmatory test for iron overload? Can J Gastroenterol Hepatol 2015;29(1):15-6 [0.03%]
刘佩昌. 遗传检测在血色病中的诊断和确认价值：铁负荷过多的检测方法？《加拿大胃肠病学与肝病学杂志》2015;29(1):15-6
Gavin Low,Guan Huang,Harini Dharmana et al.
Gavin Low et al.
Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review [0.03%]
粪钙卫蛋白在炎症性肠病及其他疾病中的应用：一篇小型综述文章
Bashaar Alibrahim,Mohammed I Aljasser,Baljinder Salh
Bashaar Alibrahim
Given the number of inflammatory disorders affecting the gastrointestinal tract directly and indirectly, coupled with the considerable overlap with functional disorders, it is evident that more useful noninvasive diagnostic tests are requir...
Andrew Szilagyi
Andrew Szilagyi
Background: Adult assimilation of lactose divides humans into dominant lactase-persistent and recessive nonpersistent phenotypes. Objectives: ...
Neel Malhotra,Nilesh Chande
Neel Malhotra
Objective: To study the use of venous thromboembolism (VTE) prophylaxis and the incidence of thrombotic events in patients with acute gastrointestinal (GI) bleeding. ...
Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis [0.03%]
无创方法（包括瞬时弹性成像）在囊性纤维化成人患者肝病筛查中的应用
Matthew D Sadler,Pam Crotty,Linda Fatovich et al.
Matthew D Sadler et al.
Background: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD) is challenging. ...
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study [0.03%]
酒精性肝炎患者死亡率的危险因素及预后模型评估：基于人口的队列研究
Jack X Q Pang,Erin Ross,Meredith A Borman et al.
Jack X Q Pang et al.
Background: Severe alcoholic hepatitis (AH) is associated with a substantial risk for short-term mortality. Objectives: To identify pro...
Increased eligibility for treatment of chronic hepatitis C infection with shortened duration of therapy: Implications for access to care and elimination strategies in Canada [0.03%]
扩大短疗程慢性丙型肝炎治疗的资格：对加拿大医疗可及性和消除战略的影响
Sergio M Borgia,Adenike Rowaiye
Sergio M Borgia
Background: All oral, highly effective direct-acting antiviral combinations, such as sofosbuvir-ledipasvir, have recently been licensed in Canada but cost as much as $67,000 for a 12-week course of therapy, representing a...
Vinaya Gaduputi,Hassan Tariq,Ariyo Ihimoyan
Vinaya Gaduputi
Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries [0.03%]
加拿大gluten-free饮食税收减免条款与各国gluten-free饮食保障制度的比较分析
Maria Ines Pinto-Sanchez,Elena F Verdu,Maria C Gordillo et al.
Maria Ines Pinto-Sanchez et al.
Celiac disease affects 1% of the North American population, with an estimated 350,000 Canadians diagnosed with this condition. The disease is triggered by the ingestion of gluten, and a lifelong, strict gluten-free diet (GFD) is the only cu...
Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? [0.03%]
特定的炎症性肠病生育知识水平能否预测女性炎症性肠病患者无子状态？
Vivian W Huang,Hsiu-Ju Chang,Karen I Kroeker et al.
Vivian W Huang et al.
Background: Women with inflammatory bowel disease (IBD) may choose to remain childless due to a lack of IBD-specific reproductive knowledge. Objectives: ...